MoneyWorks4Me

Granules India informs about closure of trading window

29 Mar 2022 Evaluate

Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and company’s Code of Conduct for Prevention of Insider Trading, Granules India has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all Insiders including Designated Persons and their immediate relatives from 01 April 2022 till 48 hours after the declaration of the audited financial results for the fourth quarter and fiscal year ended 31st March 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..